SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.
Melbourn Scientific has expanded its portfolio by adding terahertz imaging, which is "the next stage" in non-destructive film thickness evaluation technology, the company's CEO told Outsourcing-Pharma.
Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including elections to ISPE's board and a Roche exec joining Dendreon's board.
Novartis has optioned rights to apply Heptares Therapeutics’ Star GPCR technology to one of its drug development programmes in a deal that, the UK firm says, could be worth over $200m.
MDS Pharma Services’ Central Labs division is to be acquired by Czura Thornton, a private investment group that owns Chiltern, for approximately $8m (€5.4m) as part of the CRO’s repositioning.
NextPharma Technologies has added clinical trial services to its US offering to meet what product development services MD Sean Marett described as growing demand for single source outsourcing solutions.
Sygnature Chemical Services will provide synthetic chemistry services for Heptares Therapeutics GPCR drug development programme under a deal signed last week.
The USAID and USP have launched a campaign to tackle counterfeits in Cambodia and Greater Mekong Subregion, using a film to educate the population of the dangers of fakes and need to use legitimate pharmacies.
Quintiles and Cerner are combining their “unique sets of experience and expertise” to improve the efficiency of late phase research, the market for which exceeds $1bn (€677m), according to a SVP at the CRO.
Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US FDA concerns about processes used to make a once-a day version of the depression drug trazodone.
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
GlaxoSmithKline (GSK) and other pharmas concerned by parallel trade have been given encouragement by Europe’s highest court which said the EC must reconsider the company’s Spanish sale conditions.
Symphony Metro Pharma Solutions and HP Solutions have created a new application that, they claim, can help drug marketeers identify activities with the greatest revenue potential.
US firm 3M Drug Delivery Systems has set its sights on the Asia-Pacific region, with a new lab in Singapore which, it says, will help it better serve both local and international markets.
DHL is investing $15m (€10.2m) in its logistics infrastructure in Asia, increasing capacity in India to meet demand for supply chain services that are in compliance with stricter regulatory and quality requirements.
Epistem says its focus on epithelial stem cell services and growth of its CRO and biomarker businesses helped it to stave off the downturn and post a strong set of financials of the fiscal year ended June 30.
Following a “significant increase in demand” GVK Biosciences has partnered with Quantitative Solutions (QS) to develop and market clinical trial outcome databases, which they believe can improve drug development.
MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.
GSK and Walvax have entered into a long-term joint venture (JV) to serve the Chinese vaccine market, with the big pharma transferring technology to enable local production and building a manufacturing plant.
Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).
GSK has won 22 government orders for its H1N1 swine flu vaccine in the past two months, taking total sales to 440m doses which media reports suggest will earn the company £2.2bn ($3.5bn).
Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.
Pharma’s reliance on outsourcing and products developed by biotechs could cause the pace of innovation to “decline considerably”, according to experts that are concerned about the lack of funding for small businesses.
US life science firm Sigma-Aldrich has received a Michael J Fox Foundation (MJFF) grant to create knockout-rat models of Parkinson’s disease (PD) to improve preclinical drug development.
From Thursday onwards all formulations of the blood thinner heparin shipped in the US will be only 90 per cent the strength of previous version, according to the FDA.
Pharmatek has enhanced its preclinical and early stage clinical GMP supply capabilities by installing Capsugel’s Xcelodose system, becoming the first CDMO on the West Coast, US to have the equipment.
UK pharmaceutical test media supplier Cherwell Laboratories says its receipt of BSI ISO 9001:2008 accreditation demonstrates its commitment to quality.
CROs believe that finding the right principal investigators is the hardest part of recruitment, according to a survey that adds that 80 per cent of respondents would prefer to reach enrolment goals 10 per cent quicker than cut costs by 20 per cent.
Rexam has merged its Pharma, Primary Packaging and Prescription units into a new Healthcare division to keep pace with the increasingly globalized drug manufacturing industry's regulatory demands.
Hungarian drugmaker Gedeon Richter will use Phase Forward’s Clintrial software package to manage its study programmes under a deal signed late last week.
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at Sigma-Aldrich, Novavax and Pfizer’s CEO taking on an additional role.
Diabetes focused drugmaker Diamyd Medical has called in CRO Inclinix Medical to help recruit patients for “rapidly expanding” late-stage trials of its candidate diabetes vaccine Diamyd.
The AAHRPP has issued a major revision of its standards, the first time it has done so, adding sections on transnational research and the separation of business interests from ethics review.
Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family in their ongoing refusal to comply with their...
MDS Pharma Services has become the first CRO in the UK and second in the US to gain certification from the Brazilian regulatory agency after a “major client” requested it sought accreditation.
Buoyed by an increase in repeat business and deals with large pharma companies Ash Stevens has begun a $6m (€4.1m) expansion of its API manufacturing facility, with further phases planned to occur over the next six years.
French neuroscience CRO Forenap Pharma has won the contract to conduct Phase I trials of an Alzheimer’s disease treatment candidate being developed by Swiss drugmaker Anavex Life Sciences.
Caraco Pharmaceutical Laboratories has entered into a consent decree with the FDA which details a series of measures that must be fulfilled to allow the company to resume manufacturing.
US companies Savvion and Patni Life Sciences hope their new alliance help pharmas biotechs and CROs meet regulatory challenges “across the drug development cycle.”
ClearTrial has expanded its eClinical offering to create “the only system in the industry” that can provide fast and accurate project tracking, management of accrued liabilities and midstream study adjustments.
Axiom Accelerated Patient Recruitment hopes its new range of SMS, text messaging, services can help CROs and pharma sponsors reach more potential study participants.